Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 -70.26M
March 31, 2026 211.47M
December 31, 2025 -226.47M
September 30, 2025 -156.90M
June 30, 2025 -42.00M
March 31, 2025 120.08M
December 31, 2024 -6.785M
September 30, 2024 -231.04M
June 30, 2024 -17.84M
March 31, 2024 6.431M
December 31, 2023 -58.45M
September 30, 2023 248.37M
June 30, 2023 156.28M
March 31, 2023 -433.85M
December 31, 2022 -124.53M
September 30, 2022 -44.45M
June 30, 2022 -251.54M
March 31, 2022 -306.25M
December 31, 2021 95.29M
September 30, 2021 -219.04M
June 30, 2021 -184.66M
March 31, 2021 105.98M
December 31, 2020 -54.50M
September 30, 2020 -321.89M
June 30, 2020 -80.01M
Date Value
March 31, 2020 13.12M
December 31, 2019 -80.71M
September 30, 2019 -13.22M
June 30, 2019 42.24M
March 31, 2019 -170.60M
December 31, 2018 21.21M
September 30, 2018 -112.10M
June 30, 2018 -229.00M
March 31, 2018 108.53M
December 31, 2017 -92.39M
September 30, 2017 -292.36M
June 30, 2017 -67.92M
March 31, 2017 -11.59M
December 31, 2016 -15.80M
September 30, 2016 -56.12M
June 30, 2016 -124.82M
March 31, 2016 17.68M
December 31, 2015 -129.06M
September 30, 2015 4.241M
June 30, 2015 -48.22M
March 31, 2015 26.84M
December 31, 2014 -131.45M
September 30, 2014 -1.951M
June 30, 2014 -190.97M
March 31, 2014 -87.86M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Illumina, Inc. -122.00M
Thermo Fisher Scientific, Inc. -77.00M
Bio-Rad Laboratories, Inc. -66.70M
Waters Corp. 2.00M
Agilent Technologies, Inc. -1.032B